ICON plc ( NASDAQ: ICLR) has announced the suspension of its COVID vaccine study following a stop work notice from BARDA. The ...

Icon ( ($ICLR) ) just unveiled an update. On August 12, 2025, ICON plc announced that a large-scale next-generation COVID vaccine study, which had ...

The DCF model suggests that ICON is undervalued by 98.23%. Between 2018 and 2024, the company's revenues increased by 219.04% and by 145.30%, respectively. This year, ICLR will implement a program ...

William Blair wrote the update’s highlight was ICON’s impressive bookings. Net bookings beat target by 8%, and net book-to-bill of 1.02x came in well above the analyst’s 0.96x target.